Balyasny Asset Management LLC Amgen Inc Transaction History

Balyasny Asset Management LLC

$54.8 Billion
Q1 2024

A detailed history of Balyasny Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,400 shares of AMGN stock, worth $437,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,400

Previous 5,835 76.01%

Holding current value

$437,430

Previous $1.68 Million 76.31%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $442,291 - $533,901	-1,645 Reduced 28.19%	4,190 $1.19 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $34.2 Million - $38.6 Million	-133,880 Reduced 95.82%	5,835 $1.68 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $26.1 Million - $32.4 Million	-119,537 Reduced 46.11%	139,715 $37.5 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $55.5 Million - $65.7 Million	259,252 New	259,252 $57.6 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.99 Million - $2.2 Million	9,081 New	9,081 $2.2 Million

Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $39.2 Million - $44.8 Million	-196,986 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $37.8 Million - $44.3 Million	178,126 Added 944.46%	196,986 $41.9 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $5.7 Million - $6.32 Million	-24,391 Reduced 56.39%	18,860 $4.6 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $32.3 Million - $37.6 Million	-145,472 Reduced 77.08%	43,251 $10.8 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $40.8 Million - $48.6 Million	188,723 New	188,723 $43.4 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $3.15 Million - $4.18 Million	-17,299 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $14.7 Million - $18.8 Million	-77,448 Reduced 81.74%	17,299 $4.17 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $11.7 Million - $14.1 Million	67,388 Added 246.31%	94,747 $18.3 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $2.6 Million - $3.04 Million	15,572 Added 132.11%	27,359 $5.04 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $659,090 - $742,938	3,644 Added 44.75%	11,787 $2.24 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $2.3 Million - $2.68 Million	-12,890 Reduced 61.28%	8,143 $1.59 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $668,526 - $753,675	3,608 Added 20.71%	21,033 $4.36 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $2.89 Million - $3.25 Million	17,425 New	17,425 $3.22 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $1.74 Million - $2.03 Million	-10,245 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $8.48 Million - $9.48 Million	-50,252 Reduced 83.07%	10,245 $1.78 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $10.1 Million - $11.6 Million	60,497	60,497 $11.3 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Amgen Inc Transaction History